Journal of Mid-life Health Journal of Mid-life Health
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission | Subscribe | Advertise Users Online: 380  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 


    Article Cited by others

ORIGINAL ARTICLE

Ormeloxifene–Looking beyond contraception

Pati Tapasi, Chanania Kabita, Marandi Satyabhama, Hansa Jagadish

Year : 2017| Volume: 8| Issue : 1 | Page no: 17-20

   This article has been cited by
 
1 Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial
Suhail Ahmad Mir, Rifat Ara, Fiza Amin, Anjum Malik, Laraibah Hamid, Tabasum Ali, Ghulam Nabi Bader, Shahid Ud Din Wani, Mansour Almuqbil, Sultan Alshehri, Abdulhakeem M. Alshehri, Faiyaz Shakeel
Medicina. 2022; 58(11): 1503
[Pubmed]  [Google Scholar] [DOI]
2 Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses
Lakshmi S, Shanitha A, Shiny Dv, Rahul Bs, Saikant R, Shehna Sharaf, Abi Sa, Rajmohan G
Current Research in Pharmacology and Drug Discovery. 2021; : 100080
[Pubmed]  [Google Scholar] [DOI]
3 Ormeloxifene-Hyaluronic acid microfibers for breast cancer therapy
Anjali S. Kumar, S. Lakshmi, M.J. Rosemary
Materials Today: Proceedings. 2021; 45: 3800
[Pubmed]  [Google Scholar] [DOI]

 

Read this article